To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers

Recruiting now · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

This clinical study is a phase 1, randomized, double-blind, placebo-controlled, dose escalation clinical trial to evaluate the safety, pharmacokinetic and pharmacodynamics of JW0061 following topical application in Korean and Caucasians healthy adults.

Key facts

Study ID

NCT07514780

Run by

JW Pharmaceutical

People needed

104

Starts

2026-04-13

Expected to finish

2027-04-30

Last updated by the study team

2026-04-23

Who can join

Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Body weight between 50.0 kg and 90.0 kg, and BMI between 18.5 and 29.9 kg/m².
• Determined to be healthy and eligible by the investigator based on medical history, physical examination, and clinical laboratory tests.
• Capable of providing written informed consent and willing to comply with all study requirements and restrictions.

You may not qualify if…

• Presence of clinically significant scalp conditions that may interfere with safety assessments.
• History of malignancy within 5 years prior to screening.
• History of hypersensitivity or allergy to the study drug or its components.

Where it is running

• Seoul National University Hospital Clinical Trial Center — Seoul, Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.